|
|
Blood, 15 October 2006, Vol. 108, No. 8, pp. 2562-2568.
Prepublished online as a Blood First Edition Paper on June 13, 2006; DOI 10.1182/blood-2006-05-024307.
Previous Article | Table of Contents | Next Article 
HEMATOPOIESIS
Src family kinases are important negative regulators of G-CSF-dependent granulopoiesis
Craig H. Mermel,
Morgan L. McLemore,
Fulu Liu,
Shalini Pereira,
Jill Woloszynek,
Clifford A. Lowell, and
Daniel C. Link
From the Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO; Department of Medicine, University of Texas Health Science Center at San Antonio; and Department of Laboratory Medicine, University of California, San Francisco.
Granulocyte colony-stimulating factor (G-CSF) is the principal cytokine regulating granulopoiesis. Truncation mutations of the G-CSF receptor (G-CSFR) are associated with the development of acute myeloid leukemia in patients with severe congenital neutropenia. Although increased proliferative signaling by a representative G-CSFR truncation mutation (termed d715) has been documented, the molecular basis for this hyperproliferative phenotype has not been fully characterized. Given the accumulating evidence implicating Src family kinases in the transduction of cytokine receptor signals, the role of these kinases in the regulation of G-CSF signaling was examined. We show that Hck and Lyn, Src family kinases expressed in myeloid cells, are negative regulators of granulopoiesis that act at distinct stages of granulocytic differentiation. Whereas Hck regulates the G-CSF-induced proliferation of granulocytic precursors, Lyn regulates the production of myeloid progenitors. Interestingly, d715 G-CSFR myeloid progenitors were resistant to the growth-stimulating effect of treatment with a Src kinase inhibitor. Together, these data establish Lyn and Hck as key negative regulators of granulopoiesis and raise the possibility that loss of Src family kinase activation by the d715 G-CSFR may contribute to its hyperproliferative phenotype.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. D. Jack, L. Zhang, and A. D. Friedman
M-CSF elevates c-Fos and phospho-C/EBP{alpha}(S21) via ERK whereas G-CSF stimulates SHP2 phosphorylation in marrow progenitors to contribute to myeloid lineage specification
Blood,
September 3, 2009;
114(10):
2172 - 2180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Nelson, A. E. Metz, S. Li, C. A. Lowell, and C. Steele
The Absence of Hck, Fgr, and Lyn Tyrosine Kinases Augments Lung Innate Immune Responses to Pneumocystis murina
Infect. Immun.,
May 1, 2009;
77(5):
1790 - 1797.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Zhu, M. M. Augustine, T. Azuma, L. Luo, S. Yao, S. Anand, A. C. Rietz, J. Huang, H. Xu, A. S. Flies, et al.
B7-H4-deficient mice display augmented neutrophil-mediated innate immunity
Blood,
February 19, 2009;
113(8):
1759 - 1767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Shivtiel, O. Kollet, K. Lapid, A. Schajnovitz, P. Goichberg, A. Kalinkovich, E. Shezen, M. Tesio, N. Netzer, I. Petit, et al.
CD45 regulates retention, motility, and numbers of hematopoietic progenitors, and affects osteoclast remodeling of metaphyseal trabecules
J. Exp. Med.,
September 29, 2008;
205(10):
2381 - 2395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Dos Santos, C. Demur, V. Bardet, N. Prade-Houdellier, B. Payrastre, and C. Recher
A critical role for Lyn in acute myeloid leukemia
Blood,
February 15, 2008;
111(4):
2269 - 2279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hiyoshi, S. Suzu, Y. Yoshidomi, R. Hassan, H. Harada, N. Sakashita, H. Akari, K. Motoyoshi, and S. Okada
Interaction between Hck and HIV-1 Nef negatively regulates cell surface expression of M-CSF receptor
Blood,
January 1, 2008;
111(1):
243 - 250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Miranda, R. L. Redner, and D. E. Johnson
Inhibition of Src family kinases enhances retinoic acid induced gene expression and myeloid differentiation
Mol. Cancer Ther.,
December 1, 2007;
6(12):
3081 - 3090.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|